TY - JOUR
T1 - KNOW-CKD (KoreaN cohort study for Outcome in patients with Chronic Kidney Disease)
T2 - Design and methods
AU - Oh, Kook Hwan
AU - Park, Sue Kyung
AU - Park, Hayne Cho
AU - Chin, Ho Jun
AU - Chae, Dong Wan
AU - Choi, Kyu Hun
AU - Han, Seung Hyeok
AU - Yoo, Tae Hyun
AU - Lee, Kyubeck
AU - Kim, Yong Soo
AU - Chung, Wookyung
AU - Hwang, Young Hwan
AU - Kim, Soo Wan
AU - Kim, Yeong Hoon
AU - Kang, Sun Woo
AU - Park, Byung Joo
AU - Lee, Joongyub
AU - Ahn, Curie
N1 - Funding Information:
The KNOW-CKD was funded by grants 2011E3300300, 2012E3301100 and 2013E3301600 from Research of Korea Centers for Disease Control and Prevention.
PY - 2014/5/19
Y1 - 2014/5/19
N2 - Background: The progression and complications of chronic kidney disease should differ depending on the cause (C), glomerular filtration rate category (G), and albuminuria (A). The KNOW-CKD (KoreaN Cohort Study for Outcome in Patients With Chronic Kidney Disease), which is a prospective cohort study, enrolls subjects with chronic kidney disease stages 1 to 5 (predialysis). Methods/Design. Nine nephrology centers in major university hospitals throughout Korea will enroll approximately 2,450 adults with chronic kidney disease over a 5-year period from 2011 to 2015. The participating individuals will be monitored for approximately 10 years until death or until end-stage renal disease occurs. The subjects will be classified into subgroups based on the following specific causes of chronic kidney disease: glomerulonephritis, diabetic nephropathy, hypertensive nephropathy, polycystic kidney disease, and others. The eligible subjects will be evaluated at baseline for socio-demographic information, detailed personal/family history, office BP, quality of life, and health behaviors. After enrollment in the study, thorough assessments, including laboratory tests, cardiac evaluation and radiologic imaging, will be performed according to the standardized protocol. The biospecimen samples will be collected regularly. A renal event is defined by >50% decrease in estimated GFR (eGFR) from the baseline values, doubling of serum creatinine, or end-stage renal disease. The primary composite outcome consists of renal events, cardiovascular events, and death. As of September 2013, 1,470 adult chronic kidney disease subjects were enrolled in the study, including 543 subjects with glomerulonephritis, 317 with diabetic nephropathy, 294 with hypertensive nephropathy and 249 with polycystic kidney disease. Discussion. As the first large-scale chronic kidney disease cohort study to be established and maintained longitudinally for up to 10 years, the KNOW-CKD will help to clarify the natural course, complication profiles, and risk factors of Asian populations with chronic kidney disease. Trial registration. No. NCT01630486 at.
AB - Background: The progression and complications of chronic kidney disease should differ depending on the cause (C), glomerular filtration rate category (G), and albuminuria (A). The KNOW-CKD (KoreaN Cohort Study for Outcome in Patients With Chronic Kidney Disease), which is a prospective cohort study, enrolls subjects with chronic kidney disease stages 1 to 5 (predialysis). Methods/Design. Nine nephrology centers in major university hospitals throughout Korea will enroll approximately 2,450 adults with chronic kidney disease over a 5-year period from 2011 to 2015. The participating individuals will be monitored for approximately 10 years until death or until end-stage renal disease occurs. The subjects will be classified into subgroups based on the following specific causes of chronic kidney disease: glomerulonephritis, diabetic nephropathy, hypertensive nephropathy, polycystic kidney disease, and others. The eligible subjects will be evaluated at baseline for socio-demographic information, detailed personal/family history, office BP, quality of life, and health behaviors. After enrollment in the study, thorough assessments, including laboratory tests, cardiac evaluation and radiologic imaging, will be performed according to the standardized protocol. The biospecimen samples will be collected regularly. A renal event is defined by >50% decrease in estimated GFR (eGFR) from the baseline values, doubling of serum creatinine, or end-stage renal disease. The primary composite outcome consists of renal events, cardiovascular events, and death. As of September 2013, 1,470 adult chronic kidney disease subjects were enrolled in the study, including 543 subjects with glomerulonephritis, 317 with diabetic nephropathy, 294 with hypertensive nephropathy and 249 with polycystic kidney disease. Discussion. As the first large-scale chronic kidney disease cohort study to be established and maintained longitudinally for up to 10 years, the KNOW-CKD will help to clarify the natural course, complication profiles, and risk factors of Asian populations with chronic kidney disease. Trial registration. No. NCT01630486 at.
UR - http://www.scopus.com/inward/record.url?scp=84902382706&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84902382706&partnerID=8YFLogxK
U2 - 10.1186/1471-2369-15-80
DO - 10.1186/1471-2369-15-80
M3 - Article
C2 - 24884708
AN - SCOPUS:84902382706
SN - 1471-2369
VL - 15
JO - BMC Nephrology
JF - BMC Nephrology
IS - 1
M1 - 80
ER -
